Research Nester has released its report titled “Global DTaP Vaccine Market: Global Demand Analysis & Opportunity Outlook 2020-2027” that delivers detailed overview of the global DTaP vaccine market in terms of market segmentation by disease type, product type, vaccine type and end user and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The global diphtheria, tetanus and pertussis vaccine (DTaP) market is segmented by disease type, product type, vaccine type and end user. On the basis of disease type, the market can be segmented into diphtheria, tetanus and pertussis, by product type into daptacel, infanrix, kinrix, pediarix, pentacel and quadracel, by vaccine type into whole-cell and acellular and by end user into hospitals, clinics and vaccination centers.
The global diphtheria, tetanus and pertussis vaccine (DTaP) market is anticipated to grow at a modest CAGR over the forecast period i.e. 2019-2027, owing to increased awareness among the majority of the global population and the existence of high birth rates. The increase in accessibility of vaccines globally, coupled with increased investment of private sector in healthcare is anticipated to contribute to the growth of the market over the forecast period. In addition to this, lack of awareness prevailing among the mass population in underdeveloped nations could also help various market players to bring in more awareness about the vaccines and the benefits of getting vaccinated to survive various forms of illnesses that might affect the population. Also, the various initiatives taken up by World Health Organization (WHO) and United Nations International Children’s Emergency Fund (UNICEF) to create awareness about the diseases caused and its ill effects on individuals are anticipated to increase the demand for vaccines over the forecast period. Pertussis that is falling under disease type segment is anticipated to occupy the largest market share, owing to increased cases of pertussis occurring in infants as compared to other segments. Vaccination centres segment is anticipated to hold the leading market share over the forecast period.
The market in North American region is anticipated to hold the leading market share, owing to presence of major market players in the region. Additionally, the market in Europe is also expected to witness huge growth in the market over the forecast period, owing to increase in research & development activities, coupled with rise in investments in healthcare sector. Asia-Pacific is expected to witness fastest growth on the account of high population rate and increased adoption of vaccine in the region.
The various initiatives taken by WHO and UNICEF to provide low cost vaccines to low income countries globally is anticipated to drive the growth of the market over the forecast period. Also, rising birth rates and presence of large geriatric population is anticipated to boost the demand for these vaccines and are expected to drive the growth of the market over the forecast period.
However, in some cases, use of vaccines can cause adverse effects such as allergies to certain categories of individuals that may limit the demand for these vaccines among a section of population which may act as a restraint to the growth of the market over the forecast period.
This report also provides the existing competitive scenario of some of the key players of the diphtheria, tetanus and pertussis vaccine (DTaP) market which includes company profiling of GlaxoSmithKline (GLAXF), Protein Sciences Corporation , Astellas Pharma, Inc. (ALPMY), Merck & Co. (MRK), Pfizer Inc. (PFE), Lanzhou Institute of Biological Products Co., Ltd, Emergent BioSolutions, Inc. (EBS) and Sanofi S.A. (SAN). The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the diphtheria, tetanus and pertussis vaccine (DTaP) market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.